Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
Search by condition
Search By:
30 results
  • Colorectal Cancer, Ovarian Cancer, Breast Cancer, Melanoma, Lung Cancer

20-079          Phase I

A First-in-Human Phase 1b Dose Escalation Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATRC-101 in Adults with Advanced Solid Malignancies (View details on clinicaltrial.gov)

  • Head and Neck Cancer, Bladder Cancer, Melanoma, Lung Cancer

18-418          Phase III

A Multicenter, Open label, Phase III Extension Trial to Study the Long-term Safety and Efficacy in Participants with Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab Trial. (View details on clinicaltrial.gov)

  • Lung Cancer, Melanoma, Colorectal Cancer

17-607          Phase I

A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-022, an Anti-TIM-3 Monoclonal Antibody, in Patients With Advanced Solid Tumors (View details on clinicaltrial.gov)

  • Lung Cancer, Thyroid Cancer, Brain Tumors, Melanoma

20-200          Phase I

A Phase 1 Study of ERK1/2 Inhibitor JSI-1187 Administered as Monotherapy and in Combination with Dabrafenib for the Treatment of Advanced Solid Tumors with MAPK Pathway Mutations (View details on clinicaltrial.gov)

  • Lung Cancer, Melanoma, Colorectal Cancer, Head and Neck Cancer

20-057          Phase I

A Phase 1, Open Label, Dose Escalation Study of RLY-1971 in Subjects with Advanced or Metastatic Solid Tumors (View details on clinicaltrial.gov)

  • Melanoma, Metastatic/Advanced Cancer, Lung Cancer

20-286          Phase I

A Phase 1, Open-Label, Dose-Escalation, and Dose-Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SRK-181 Administered Alone or in Combination with a Checkpoint Inhibitor in Patients with Locally Advanced or Metastatic Solid Tumors (View details on clinicaltrial.gov)

  • Bladder Cancer, Head and Neck Cancer, Metastatic/Advanced Cancer, Melanoma, Lung Cancer

17-330          Phase I

A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Subjects with Resected Solid Tumors and in Combination with Pembrolizumab in Subjects with Unresectable Solid Tumors (View details on clinicaltrial.gov)

  • Breast Cancer, Melanoma, Head and Neck Cancer

20-135          Phase I

A Phase 1, Open-Label, Multicenter, Dose Escalation and Expansion Study of ONCR-177, an Oncolytic Herpes Simplex Virus for Intratumoral Injection, Alone and in Combination with PD-1 Blockade in Adult Subjects with Advanced and/or Refractory Cutaneous, Subcutaneous or Metastatic Nodal Solid Tumors (View details on clinicaltrial.gov)

  • Merkel Cell Carcinoma, Breast Cancer, Metastatic/Advanced Cancer, Melanoma, Head and Neck Cancer

17-334          Phase I

A Phase 1, Open-Label, Multicenter, Dose Escalation Study or MRNA-2416, A Lipid Nanoparticle Encapsulated MRNA Encoding Human OX4OL, For Intratumoral Injection to Patients with Advanced Malignancies (View details on clinicaltrial.gov)

  • Melanoma

20-351          Phase I

A Phase 1, Open-Label, Multiple-Ascending Dose Study of the Safety and Tolerability of T3011 in Advanced Cutaneous or Subcutaneous Malignancies (View details on clinicaltrial.gov)

Showing 1 - 10 of 30 results